Journal of Commercial Biotechnology — March 2008

The March 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract of each article:

Volume 14, Issue 2


Yali Friedman


Export compliance for life sciencesPDF
John Avellanet
A new approach to improve technology commercialisation in university medical schoolsPDF
Courtney Price, Richard Huston, Arlen D Meyers
Biotechnology business models work: Evidence from the pharmaceutical marketplacePDF
J Leslie Glick
Valuing biotechnology companies: Does classification by technology type help?PDF
Jacqueline Loh, Robert Brooks
Risk management for the biotechnology industry: A Canadian perspectivePDF
Sandra Vanderbyl, Sherry Kobelak
Singapore’s biomedical sciences landscapePDF
Keat-Chuan Yeoh
Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: A commentary from the bioethical viewpointPDF
Yoshihiro Okada, Kazuo N Watanabe

Legal and Regulatory Updates

Legal and regulatory updatePDF
Gerry Kamstra, John Wilkinson

Conference Report

Maryland and Virginia unite at 2007 Mid-Atlantic Bio ConferencePDF
Harley King

Book Reviews

Book Review: Stem cell wars: Inside stories from the FrontlinesPDF
Grant H Skrepnek


Scroll to Top